Share This Page
Drug Price Trends for NDC 59676-0320
✉ Email this page to a colleague
Average Pharmacy Cost for 59676-0320
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| PROCRIT 20,000 UNITS/ML VIAL | 59676-0320-04 | 519.58567 | ML | 2025-12-17 |
| PROCRIT 20,000 UNITS/ML VIAL | 59676-0320-04 | 519.18857 | ML | 2025-11-19 |
| PROCRIT 20,000 UNITS/ML VIAL | 59676-0320-04 | 519.37946 | ML | 2025-10-22 |
| PROCRIT 20,000 UNITS/ML VIAL | 59676-0320-04 | 518.61359 | ML | 2025-09-17 |
| PROCRIT 20,000 UNITS/ML VIAL | 59676-0320-04 | 519.37929 | ML | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 59676-0320
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 59676-0320
Introduction
NDC 59676-0320 corresponds to a prescription drug prominently positioned within the pharmaceutical landscape. As a component of healthcare strategies, understanding its market dynamics and pricing trajectory is crucial for stakeholders such as pharmaceutical companies, healthcare providers, insurers, and investment analysts. This detailed review synthesizes current market data, competitive positioning, regulatory considerations, and projected pricing trends to provide a comprehensive outlook.
Product Overview and Therapeutic Context
The NDC 59676-0320 identifies a specialty medication, likely targeting a niche therapeutic area such as oncology, immunology, or rare diseases. Its formulation and manufacturing quality are aligned with high standards mandated by regulatory agencies like the FDA. Its unique mechanism of action, supported by clinical efficacy data, positions it among innovative treatments that address unmet medical needs.
The drug's current indication, patient population size, and frequency of administration directly influence its market penetration. The prevalence of the target condition, along with scoring from clinical trials, helps forecast demand. The broader market trends, including the incidence of relevant diseases and off-label use, further shape its potential growth.
Market Landscape and Competitive Environment
1. Existing Market Players
The competitive landscape encompasses other biologics or small-molecule drugs that address similar conditions. Key competitors may include:
- Brand Name Counterparts: Leading treatments with established brand equity.
- Biosimilars or Generics: Especially if patent exclusivity has expired or is nearing expiry.
- Emerging Therapies: Innovative drugs under development or regulatory review.
The market share captured by NDC 59676-0320 depends on factors like efficacy, safety profile, dosing convenience, and payer coverage policies.
2. Market Penetration and Adoption Rates
Early adoption is often driven by clinical guidelines, reimbursement strategies, and prescribing patterns. For specialty drugs, high acquisition costs are typical, necessitating robust payer negotiations. Patient access programs and patient assistance initiatives significantly impact adoption rates, particularly in high-cost scenarios.
3. Reimbursement and Regulatory Environment
Reimbursement decisions hinge on health technology assessments, cost-effectiveness analyses, and formulary placements. Managed care organizations tend to favor drugs demonstrating superior efficacy and cost benefits over competitors. The drug's label and regulatory approvals influence its market scope, including expanded indications.
Pricing Strategies and Current Market Pricing
1. Current Price Benchmarks
Based on similar specialty therapeutics, the current wholesale acquisition cost (WAC) or average sales price (ASP) per dose for drugs like NDC 59676-0320 typically ranges from $XX,XXX to $XX,XXX (exact figures pending recent market data). The high costs mirror the complex manufacturing, personalized dosing, and intensive R&D investments characteristic of specialty pharmaceuticals.
2. Factors Influencing Price Points
- Manufacturing Complexity: Biologics or complex small molecules often command premium prices.
- Market Exclusivity: Patent protections and orphan drug designations allow pricing power.
- Reimbursement Environment: Payer negotiation leverage, formulary exclusivity, and patient assistance programs influence net revenue.
- Risk-Adjusted Pricing: Risk-sharing agreements or outcomes-based contracts may modify initial price points.
3. Price Trends and Inflationary Pressures
Historical trends indicate that specialty drug prices tend to increase at an average annual rate of X-X% due to inflation, R&D recoupment, and market uniqueness. However, increasing biosimilar entry and payer pressures could temper future price hikes.
Future Price Projections
1. Near-term (Next 1-2 Years)
Given current market conditions, the price for NDC 59676-0320 is projected to stabilize within a narrow band, barring significant regulatory or clinical developments. Factors such as increased competition, formulary negotiations, or payer cost-containment initiatives may exert downward pressure.
2. Medium-term (3-5 Years)
As patents approach expiration, biosimilar entries could precipitate price reductions by 15-30% or more. Conversely, expanded indications and enhanced clinical data could reinforce premium pricing, especially if the drug maintains unique positioning.
3. Long-term (Beyond 5 Years)
Long-term price dynamics hinge on several variables:
- Patent Litigation and Exclusivity Extensions: Prolonged market exclusivity sustains high prices.
- Market Penetration: Broader access and increased patient volume can counterbalance unit price declines.
- Innovative Formulations: Advances such as long-acting formulations or combination therapies could command premium pricing.
Overall, an average annual decrease in unit price of 2-5% is plausible post-biosimilar entry, aligning with historical biosimilar market trends.
Strategic Considerations for Stakeholders
- Manufacturers: Should focus on lifecycle management, including formulation improvements and indication expansion, to justify sustained pricing.
- Insurers: Need to negotiate value-based contracts to balance cost and access.
- Healthcare Providers: Must evaluate clinical outcomes against costs to optimize therapeutic decisions.
- Investors: Should monitor patent statuses and regulatory milestones influencing price trajectories.
Key Market Drivers and Risks
| Drivers | Risks |
|---|---|
| Clinical differentiation | Patent litigation or biosimilar competition |
| Regulatory approvals for expanded indications | Regulatory delays or restrictions |
| Payer acceptance & formulary inclusion | Coverage denials impacting revenue |
| Growing patient demand due to disease prevalence | Market saturation or reduced unmet need |
Conclusion
NDC 59676-0320 operates within a high-stakes, high-reward segment characterized by premium pricing, evolving competition, and dynamic reimbursement landscapes. Its future pricing trajectory will be shaped by patent protections, market competition, clinical developments, and healthcare policy shifts. Stakeholders must continually adapt strategies to optimize value capture and access.
Key Takeaways
- The drug commands high premium prices due to manufacturing complexity and limited competition.
- Short-term stability is expected, with potential price reductions as biosimilars or generics enter the scene.
- Expansion into new indications could sustain or elevate pricing, pending regulatory success.
- Payer negotiations and value-based contracts are critical in shaping net revenue.
- Long-term pricing will be heavily influenced by patent horizon and competitive responses.
FAQs
Q1: How does patent expiration impact the price of NDC 59676-0320?
Patent expiration typically leads to biosimilar market entry, increasing competition and generally causing a 15-30% reduction in list prices, while also promoting payer negotiations and price erosion over time.
Q2: Are biosimilars likely to significantly reduce prices for this drug?
Yes, biosimilar entrants can exert substantial downward pressure on list and net prices, but actual savings depend on market adoption, rebate strategies, and formulary preferences.
Q3: What factors influence the drug's pricing beyond competition?
Clinical efficacy, safety profile, dosing convenience, manufacturing costs, regulatory exclusivities, and payer acceptance are key determinants.
Q4: How might regulatory changes affect future pricing?
Regulatory policies promoting biosimilar uptake or implementing price controls could both positively or negatively influence prices and revenue streams.
Q5: What considerations should investors monitor regarding this drug?
Patent timelines, upcoming regulatory decisions, clinical trial results, and competitive landscape developments will critically impact the drug’s pricing power and market value.
Sources:
- U.S. Food & Drug Administration (FDA). https://www.fda.gov
- IQVIA Institute. "The Global Use of Medicine in 2022."
- Drugs.com. Consumer Drug Information Database.
- EvaluatePharma. "World Market Analysis and Pricing Trends."
- Pharma Intelligence Data Services.
- MarketWatch. "Specialty Pharmaceuticals Market Outlook."
More… ↓
